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The abcc6a Gene Expression Is Required for Normal
Zebrafish Development
Qiaoli Li1,8, Sara Sadowski1,8, Michael Frank1, Chunli Chai2,7, Andras Va´radi3, Shiu-Ying Ho4, Hong Lou5,
Michael Dean6, Christine Thisse2, Bernard Thisse2 and Jouni Uitto1,4
Pseudoxanthoma elasticum (PXE) is caused by mutations in the ABCC6 gene, which encodes a putative efflux
transporter, ABCC6. The zebrafish (Danio rerio) has two ABCC6-related sequences. To study the function of
abcc6 during zebrafish development, the mRNA expression levels were measured using RT-PCR and in situ
hybridization. The abcc6a showed a relatively high level of expression at 5 days post-fertilization (d.p.f.) and the
expression was specific to the Kupffer’s vesicles. The abcc6b expression was evident at 6 hours post-fertilization
(h.p.f.) and remained high up to 8 d.p.f., corresponding to embryonic kidney proximal tubules. Morpholinos
were designed to both genes to prevent pre-mRNA splicing and block translation. Injection of the abcc6a
morpholinos into 1–4 cell zebrafish embryos decreased gene expression by 54–81%, and induced a phenotype,
pericardial edema and curled tail associated with death at around 8 d.p.f. Microinjecting zebrafish embryos with
full-length mouse Abcc6 mRNA together with the morpholino completely rescued this phenotype. No
phenotypic changes were observed when the abcc6b gene morpholino was injected into embryos with knock-
down efficiency of 100%. These results suggest that abcc6a is an essential gene for normal zebrafish
development and provide insight into the function of ABCC6, the gene mutated in PXE.
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INTRODUCTION
Pseudoxanthoma elasticum (PXE) is a heritable disease
characterized by ectopic mineralization of connective
tissues, with clinical manifestations primarily in the skin,
the eyes, and the blood vessels (for review, see Li et al., 2009;
Uitto et al., 2010). PXE is of late onset, the diagnosis being made
approximately at the age of 13 years on average, yet the tissue
involvement is progressive, leading to considerable morbidity
and even mortality. The classic forms of PXE, inherited in an
autosomal recessive pattern (Ringpfeil et al., 2006), are
caused by mutations in the ABCC6 gene, a member of the
ATP binding cassette family C, member 6, which encodes a
putative transmembrane transporter protein, ABCC6 (also
known as MRP6) (Pfendner et al., 2007; Li et al., 2009).
In humans, ABCC6 is primarily expressed in the liver, to a
lesser extent in the kidneys, and at very low level, if at all, in
tissues clinically affected in PXE. These observations, together
with recent grafting and parabiotic mouse experiments (Jiang
et al., 2009, 2010), have suggested that PXE is a metabolic
disorder, potentially reflecting the altered balance within the
mineralization/anti-mineralization network in the circulation
and in the peripheral connective tissues. Nevertheless, the
nature of molecules transported in vivo by ABCC6 is currently
unknown, and the precise role of this efflux transporter
protein, which resides in the baso-lateral surface of hepato-
cytes, is unclear.
We have previously developed an Abcc6/ mouse by
targeted ablation of the corresponding mouse gene (Klement
et al., 2005). This mouse model recapitulates the genetic,
histopathological, and ultrastructural features of PXE, and has
served as a useful model to investigate the pathomechanistic
details of PXE. Specifically, these mice show calcium/
phosphate deposition in the peripheral connective tissues
in the skin, the eyes, and the cardiovascular system. The
drawback of this mouse model is that it takes several months
to test the efficacy of different pharmacological or dietary
manipulations on the mineralization process.
As an alternative model system to study ABCC6 function,
we have initiated work on the zebrafish (Danio rerio) which
has nearly the same complement of ABC genes as mammals
(for reviews on zebrafish, see Barut and Zon, 2000; Chen and
Ekker, 2004; Dean and Annilo, 2005; Annilo et al., 2006).
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Several characteristics favor the choice of zebrafish for
genetic screening studies. First, zebrafish are easy to maintain
in large numbers in a laboratory setting. Second, their
development is very rapid, the major organs, including the
skin, being largely developed in 5–6 days. Finally, each
female produces about 50–100 embryos per day. The
zebrafish also presents with advantages for embryological
analysis: its embryos develop externally and are largely
transparent for the first 36 hours of development. In addition,
the expression of specific genes can be readily manipulated
using morpholino-based anti-sense oligonucleotides (Shan,
2009). Thus, in this study, we have performed experiments to
investigate the expression of abcc6 genes in zebrafish to
determine whether these genes are essential to embryonic
development and whether reduction in gene expression by
morpholinos confers a visible phenotype.
RESULTS
Analysis of the abcc6 genes in zebrafish
The presence of two ABCC6-related sequences, abcc6a
(ENSDART00000065433) and abcc6b (ENSDART000000
42812), was discovered by analysis of the on-line gene
database (Ensembl Database), and these two genes were
mapped to zebrafish chromosomes 6 and 3, respectively.
The abcc6a gene in zebrafish consists of 33 exons ranging
from 3 to 311 bp in size (Figure 1a) and the predicted
amino acid sequence of the zebrafish abcc6a protein
contains 1529 amino acids (Figure 1b). The abcc6b gene
4 5 8 10 11 12 13 14     
NBF1 NBF2
MO1 MO2
TMD0 TMD1 TMD2
abcc6a (Z)
1 2 3 9 11 12 13 19 20    22 23 24 25 26 28 29 30 31 32
TMD0 TMD1 NBF1 TMD2 NBF2
MO2
abcc6b (Z)
1 2 3 6 7 9 15 16 1718 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
1817151087654
Figure 1. Schematic representation of the zebrafish abcc6 genes and amino acid sequence of the zebrafish abcc6 proteins. (a) The abcc6a gene consists
of 33 exons and abcc6b consists of 32 exons numbered on the top, and the coding segments for transmembrane domains (TMDs) and nucleotide-binding
folds (NBFs, dark green) are underlined. Note the location corresponding to the two morpholinos (MO1 and MO2) used in this study. (b) Amino acid
sequences of zebrafish abcc6 proteins predict the presence of membrane-spanning helices (in red) and nucleotide-binding folds (underlined). Note the presence
of Walker A and B motifs (bold) and the ABC signature sequence (blue).
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consists of 32 exons ranging from 6 to 311 bp in size
(Figure 1a) and the predicted protein contains 1528 amino
acids (Figure 1b). The positions of the conserved protein
sequences for nucleotide-binding folds (NBF1 and NBF2), the
three transmembrane-spanning domains (TMD0, TMD1, and
TMD2) consisting of 5, 6 and 6 transmembrane segments,
respectively, as well as those for Walker A, ABC signature,
and Walker B motifs were identified in the protein sequence
(Figure 1b) (Tusna´dy and Simon, 1998, 2001). The two abcc6
proteins in zebrafish have B70% sequence identity at the
amino acid sequence level. Comparison of the zebrafish
abcc6a protein with other ABCC6 orthologs revealed 47%
identity to human, and 45% identity to both mouse and rat.
Comparison of the zebrafish NBF1 showed 65% identity to
human NBF1, and 61% identity to mouse and rat NBF1.
Comparison of the zebrafish NBF2 showed 58% identity to
human NBF2 and 57% identity to mouse and rat NBF2.
We performed a phylogenetic analysis to determine the
relationship between zebrafish abcc6 and the other members
of the ABCC subfamily, including ABCC1, ABCC2, ABCC3,
and ABCC10 proteins, by constructing a neighbor-joining
phylogenetic tree (Figure 2). The zebrafish abcc6 proteins are
most closely related to the Tetraodon nigroviridis and Fugu
rubripes Abcc6 proteins. A cluster of ABCC6 subfamily
included the zebrafish abcc6 proteins, a finding supported
by high bootstrap values. Therefore, although the zebrafish
abcc6 genes have diverged considerably from the mamma-
lian genes, they are ABCC6 orthologs. Collectively, zebrafish
abcc6 genes have a high degree of conservation as compared
to corresponding vertebrate genes, and critical functional
elements of the protein, including the NBFs, are conserved.
Developmental expression of zebrafish abcc6a and abcc6b by
RT-PCR and in situ hybridization
Zebrafish embryos were collected during the first 8 days of
development and abcc6a and abcc6b mRNA expression
profiles were determined by RT-PCR. Low level of expression
of the abcc6a gene was detected during the first 4 days
post-fertilization (d.p.f.) (Figure 3a). However, a drastic
increase on the fifth d.p.f. was noted (Figure 3a). abcc6b
gene expression at an mRNA level was detected at 6 h.p.f.
and remained high thereafter (Figure 3a).
To determine the spatial expression of abcc6, whole mount
in situ hybridization (ISH) was performed using probes
specific for abcc6a and abcc6b (Figure 3). In situ hybridiza-
tion using an antisense RNA probe for abcc6a gene showed
expression in forerunner cells at gastrulation, then in the
Kupffer’s vesicle (which derives from the forerunner cells) as
well as in the tail bud. Specific expression in these regions
is observed during somitogenesis stages (Figure 3b). In situ
hybridization using an antisense probe for abcc6b gene also
showed a specific expression pattern. The most prominent
site of expression corresponds to the anterior part of the
embryonic kidney proximal straight tubule (Wingert et al.,
2007). Another site of expression, although far less intense
but still specific, is the cells of the enveloping layer (EVL)
at the gastrula stage (Figure 3c).
Morpholino ‘‘knock-down’’ of abcc6a expression
To determine whether the zebrafish abcc6a gene is essential
for embryonic development or might confer a visible
phenotype, two morpholino oligonucleotides were designed
to correspond to abcc6a sequences: MO1 corresponds to
the sequence including the ATG translation initiation site
(Figure 1a); MO2 was placed at the splice donor site at exon
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Figure 2. Phylogenetic tree of the zebrafish abcc6 proteins. The phylogenetic
relationship between zebrafish abcc6 sequences (boxed) and the other
members of the ABCC6 subfamily estimated by the neighbor-joining method.
The bar indicates 10% divergence and the percent bootstrap values out of
1,000 replications are indicated at the nodes. For designation of the species
analyzed, see Materials and Methods.
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Figure 3. Temporal and spatial expression of abcc6a and abcc6b expression
in normal zebrafish embryos. (a) Zebrafish embryos were collected at 0 hours,
6 hours, and 1–8 days post fertilization (d.p.f.), and total RNA was isolated and
cDNA prepared. mRNA levels were quantified using RT-PCR with specific
primer pairs. The level of expression was corrected by the level of b-actin in
the same RNA preparations. (b) In situ hybridization revealed abcc6a
expression in the Kupffer’s vesicles and tail bud. (c) In situ hybridization
revealed abcc6b gene expression in the enveloping layer and embryonic
kidney proximal straight tubules.
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7–intron 7 border (Figure 1a). Injection of the morpholinos
into 1–4 cell zebrafish embryos was performed, followed by
monitoring for viability, morphology, and mRNA expression
levels. With both morpholino oligonucleotides, there was
a significant decrease in abcc6a mRNA expression levels.
Specifically, there was a 54% decrease with the MO1 and
an 81% decrease with the MO2 at 5 d.p.f. The efficiency
of the splice site morpholino, MO2, was also monitored
by analysis of splicing using PCR amplification of abcc6a
exons 7 and 8 junction of the injected zebrafish embryo
cDNA (Figure 4a). This approach, using a forward primer
on exon 7 and a reverse primer on exon 8, revealed that
most of the pre-mRNA species were not appropriately
spliced and retained the 108 bp intron 7 in the sequence.
Injection with the same amount of standard control morpho-
lino (scMO) was performed as control, which did not alter
the abcc6a mRNA splicing (Figure 4a). Collectively, these
observations indicate that the newly designed morpholinos
effectively downregulated expression of the abcc6a gene
at the mRNA level.
Phenotypic consequences of morpholino ‘‘knock-down’’ and
mRNA rescue
The consequences of the ‘‘knock-down’’ of abcc6a expres-
sion were followed by survival rate and morphological
observations of injected embryos (Table 1). The changes in
morpholino-injected embryos were compared with those
embryos injected with phenol red dye or a standard control
morpholino (scMO), which has no target and no biological
function in zebrafish, as controls. Injection of phenol red
or standard control morpholino did not cause any changes
and the embryos were indistinguishable from the uninjected
controls (Figure 5 and Table 1). Observation of 1 d.p.f.
embryos suggested a shortening of the body, delay of the
development of the head, decreased tail length, and curving
of the caudal part of the fish (Figure 5a). At 3 d.p.f. these
changes were more prominent and development of peri-
cardial edema was noted (Figure 5b). On 5 d.p.f., the pericardial
edema was very prominent, and this was more severe in fish
that were receiving MO2 (Figure 5c), consistent with more
efficient suppression of the corresponding mRNA expression.
The treated embryos became incapacitated and eventually
died around 8 d.p.f. (not shown).
To examine the specificity of the effects of morpholino
‘‘knock-down’’, mRNA rescue experiments were performed.
In these experiments, full-length mouse Abcc6 mRNA was
injected to the embryos together with MO2, which was
shown to result in the most severe phenotype. Co-injection of
the Abcc6 mRNA together with MO2 into 1–4 cell embryos
completely reversed the phenotypic effects of the morpholino
in each embryo, and at 5 d.p.f. the rescued embryos
had essentially the same morphology as control embryos
(Figure 6). These observations attest to the critical importance
of abcc6a in the development of zebrafish and also
emphasize the specificity of the morpholinos used to arrest
the abcc6a expression.
Morpholino ‘‘knock-down’’ of abcc6b expression and lack
of phenotypic consequences
A splice donor site morpholino was designed to target the
abcc6b gene. This morpholino was placed at exon 18–intron
18 border (Figure 1a). Injection of the morpholino into 1–4
cell zebrafish embryos was carried out, followed by survival
rate, pre-mRNA splicing analysis, and morphology observation.
Table 1. Survival and development of phenotype in zebrafish injected with abcc6a or abcc6b morpholinos1
3 d.p.f.3 5 d.p.f.3
Experimental group (morpholino) No. of fish Survival (%) Phenotype (%) Survival (%) Phenotype (%)
abcc6a 191 52* 83* 45* 63*
abcc6b 126 77 0 77 0
scMO2 177 79 0 77 0
Uninjected control 207 87 0 84 0
1This is a representative experiment in which all groups were followed in parallel. Similar results were obtained in 410 additional experiments with the
same design.
2scMO, standard control morpholino with no biological function and no target sequence in the zebrafish genome (Robu et al., 2007).
3Statistical significance between the abcc6a and scMO groups (Fisher’s exact test: *Po0.0001). (For details, see Materials and Methods.)
Forward Forward MO2
EXON 19
Reverse
MO2
EXON 7 EXON 8
MO2
282 bp
174 bp
300 bp
421 bp
299 bp
MO2 C
500 bp
300 bp
200 bp
C
Reverse
EXON 18
abcc6a abcc6b
Figure 4. ‘‘Knock-down’’ of abcc6a and abcc6b expression by splice site
morpholinos. The consequences of MO2, which is placed on the exon
7/intron 7 border on abcc6a pre-mRNA or at the exon 18/intron 18 border
on abcc6b pre-mRNA, splicing were determined by RT-PCR. The results show
retention of intron 7 (282-bp fragment) in the majority of mRNA transcripts
as compared to normally transcribed control (C,174 bp) when abcc6a MO2
was injected to embryos (a). The 122-bp intron 18 was retained in 100%
of pre-mRNA transcripts (421 bp) as compared to normally transcribed control
(C,299 bp) when abcc6b MO2 was injected to embryos (b). C, standard
control morpholino-injected embryos.
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The efficiency of the morpholino was monitored by an
analysis of splicing using PCR amplification of abcc6b
exons 18 and 19 of the injected embryo cDNA at 3 d.p.f.
(Figure 4b). The result showed that pre-mRNA (100%) was
not appropriately spliced and retained the 122 bp intron 18 in
the sequence. However, the abcc6b knock-down zebrafish
did not reveal any morphological changes when compared to
uninjected control or standard control morpholino-injected
embryos at 1, 3, and 5 d.p.f. (Figure 5a–c).
DISCUSSION
The human ABCC6 gene encodes a putative transmembrane
efflux transporter protein, ABCC6, a member of the family of
ATP binding cassette (ABC) proteins (Borst and Elferink,
abcc6a
MO1
abcc6a
MO2
Standard
control MO
abcc6b
MO2
1 d.p.f.
5 d.p.f.
3 d.p.f.
Figure 5. The morpholino ‘‘knock-down’’ of abcc6 expression. Phenotypic appearance of zebrafish embryos injected with morpholinos at 1–4 cell
stage. (a) 1 d.p.f.; (b) 3 d.p.f.; (c) 5 d.p.f. The pericardial edema is indicated by arrows. The morpholinos injected are indicated on the top of each column.
Control: standard control morpholino-injected embryos as control.
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2002; Dean, 2005; Szaka´cs et al., 2008). Mutations in this
gene have been found to cause PXE (Pfendner et al., 2007).
In humans, the ABCC6 gene is primarily expressed in the liver
and to a lesser extent in the kidneys, but at a very low level,
if at all, in tissues clinically affected by PXE (Belinsky and
Kruh, 1999; Scheffer et al., 2002). This situation has led to a
dilemma concerning the pathomechanism of PXE, and two
contrasting hypotheses to explain the pathogenesis of
mineralization have been proposed. ‘‘The metabolic hypoth-
esis’’ postulates that absence of functional ABCC6 activity,
primarily in the liver, results in deficiency of circulating
factor(s) that are physiologically required to prevent aberrant
mineralization under normal calcium and phosphate homeo-
static conditions (Uitto et al., 2001; Li et al., 2009). In support
of the metabolic hypothesis, there are several both clinical
and experimental observations in patients with PXE as well
as in the Abcc6/ mouse that serves as a transgenic model
for human PXE (Li et al., 2009). ‘‘The PXE cell hypothesis’’
postulates that lack of ABCC6 expression in the resident cells
in affected tissues, such as skin fibroblasts or arterial smooth
muscle cells, alters their biosynthetic expression profile and
cell–cell and cell–matrix interactions associated with changes
in the proliferative capacity (Passi et al., 1996; Quaglino
et al., 2000).
In this study, a RT-PCR method was established to measure
abcc6a mRNA expression levels, and to show the presence of
abcc6a mRNA in whole-mount zebrafish by in situ hybridi-
zation. ‘‘Knock-down’’ of abcc6a using morpholino oligonu-
cleotides showed a severe, visible phenotype, and
accumulation of fluid around the heart of the developing
zebrafish. The specificity of the effects of morpholinos was
attested to by the fact that co-injection of full length mouse
Abcc6 mRNA fully rescued the phenotype.
Although the abcc6a morpholino ‘‘knock-down’’ clearly
elicited a phenotype during the early stages of zebrafish
development, the relationship of these findings to PXE,
caused by inactivation of the ABCC6 efflux transporter, are
not clear. Specifically, the characteristic pathogenic conse-
quence of the absence of ABCC6 activity in patients with
PXE or in Abcc6/ mice, which recapitulate the features
of PXE (Gorgels et al., 2005; Klement et al., 2005), is ectopic
mineralization of soft connective tissues. Attempts to find
ectopic mineralization in developing zebrafish treated with
the morpholinos were unyielding. It should be noted,
however, that connective tissue mineralization in PXE and
its mouse model, Abcc6/, is not noted at birth but develops
later in life. The clinical diagnosis of PXE in humans is usually
made in the teens or early twenties of affected individuals.
The earliest signs of mineralization in Abcc6/ mice are
evident at 5–6 weeks, shortly after weaning (Jiang et al.,
2007). Although zebrafish are largely developed at
B5–6 d.p.f., the morpholino phenotype resulted in death at
8 d.p.f. and the mineralization phenotype, if developmentally
corresponding to human or mouse pathogenesis of PXE, might
occur much later.
It should also be noted that PXE is an autosomal recessive
disease, although heterozygous carriers of a mutation in one
of the ABCC6 alleles have been suggested to demonstrate
subclinical findings in the eyes in terms of angioid streaks
and presence of subtle histopathological changes in the skin
without overt cutaneous phenotype (Martin et al., 2007,
2008). The morpholino ‘‘knock-down’’ resulted in 54–81%
reduction in abcc6a expression, as determined at the mRNA
level. Thus, this zebrafish model did not display a full
‘‘knock-out’’ of the abcc6a gene, and the expected pheno-
type might be more akin to that noted in heterozygous
carriers of PXE. Nevertheless, our observations attest
to the critical importance of the abcc6a gene expression
in zebrafish development. The discordance between the
human, mouse and zebrafish phenotypes also raises the
possibility that the ABCC6 gene product might have different
biological functions depending on the species, or that unlike
other members of the ABC family, this transmembrane
protein is not acting as a transporter in zebrafish. If this
is the case, the abcc6 knock-down in zebrafish is not a
good model for PXE, which is characterized by a chronic,
progressive and late-onset mineralization process.
In summary, this study has provided novel insight into
the role of the ABCC6 gene harboring mutations in PXE.
In zebrafish, this gene appears to be critical in the early
embryonic development, but the direct relevance of these
observations to human PXE remains to be explored.
MO2 MO2+mAbcc6 mRNA Control
Figure 6. mRNA rescue. Co-injection of full-length mouse Abcc6 mRNA together with abcc6a morpholino MO2 fully rescued the phenotype at 5 d.p.f.
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MATERIALS AND METHODS
Identification and sequence analysis of ABCC6-related
genes in zebrafish
The Ensembl database was searched for human ABCC6-related
genes; two genes, in chromosomes 6 and 3, were identified
and designated as abcc6a and abcc6b, respectively. The pre-
dicted zebrafish full-length abcc6 amino acid sequences, as well
as various subdomain sequences, were aligned with human
(Homo sapiens), mouse (Mus musculus), and rat (Rattus rattus)
sequences using the ClustalW program (http://www.ebi.ac.uk/
clustalw/).
Phylogenetic analysis
The genomic sequences of abcc6 loci were extracted from the
Ensembl Database. The predicted zebrafish full length abcc6a and
abcc6b amino acid sequence was aligned with Tni (Tetraodon
nigroviridis), Fru (Fugu rubripes), Gga (Gallus gallus), Hsa (Homo
sapiens), Rat (Rattus rattus), and Mus (Mus musculus) sequences
using ClustalW (http://www.ebi.ac.uk/clustalw/). The neighbor-join-
ing (NJ) method with the standard Kimura two-parameter model was
used for the construction of the phylogenetic tree using the Molecular
Evolution Genetics Analysis software version 3.1 (Kumar and Gadagkar,
2001). The statistical reliance of NJ tree branches was evaluated using
1,000 bootstrap samples. The divergence was determined by the
distance matrix method.
Maintenance of zebrafish
Wild-type zebrafish were maintained under standard conditions at
28.5 1C and the zebrafish embryos were maintained also at 28.5 1C
in a special embryo medium. All animals were housed in the
zebrafish facility of Thomas Jefferson University and were cared for
and used in accordance with University Institutional Animal Care
and Use Committee guidelines.
Morpholinos
Morpholino oligonucleotides were obtained from Gene Tools,
LLC (Corvalis, OR). The morpholino oligomer target sequences were
from 50 to 30, as follows (Brackets around morpholino sequences,
exonic sequences in capital letters, and intronic sequences in lower
case letters):
abcc6a MO1: ATG site morpholino
CTCAGGACCAGACGAGTGA[(ATG)GATACCTTTTGCAGTCTA
AGTG]
abcc6a MO2: Splice donor site morpholino
AGATCCTCTTCTGGTGGTT[CAGCGGgtaggcaattaaaatgatt]ttg
aatacta
abcc6b MO2: Splice donor site morpholino
GCAACAGAGATTGG[AGAGAAGgtgcataatatggattag]tttttatgtat
Standard control morpholino (antisense) (scMO):
CCTCTTACCTCAGTTACAATTTATA
Injection of the morpholinos (22.5 ng of abcc6a MO1; 15.1 ng of
abcc6a MO2; 10 ng of abcc6b MO2; 22.5 ng of scMO) into 1–4 cell
embryos was performed and the embryos were followed for viability,
morphology, and mRNA expression levels. Embryos from the same
matings were injected with an equal volume of phenol red/nuclease-
free water mixture as a control and some embryos served as
uninjected controls.
Total RNA isolation and cDNA synthesis
Zebrafish embryos were collected 0 and 6 hours and 1–8 days
post-fertilization. Embryos were disintegrated by passing through a
20-G needle, and total RNA was prepared using TRizol reagent
(Invitrogen, Carlsbad, CA). To remove contaminating genomic DNA,
RNase-free DNase I digestion was carried out (Fisher Scientific, St
Louis, MO). One microgram of total RNA was reverse transcribed
using Superscript III First-Strand cDNA synthesis kit (Invitrogen)
according to the manufacturer’s protocol. Controls were performed
by omitting the reverse transcriptase enzyme. All cDNAs were stored
at 20 1C for future use.
PCR amplification of cDNA
Abcc6-specific primers were designed using Primer 3 software
according to the zebrafish abcc6 sequences from the Ensembl
Database (http://www.ensembl.org/index.html). The abcc6a primers
(Fwd: 50-TTGACCCTCTATGGGACTGG-30, Rev: 50-GGACCCAC
AGGTAGATGCAC-30) were placed on exons 1 and 2 of the
corresponding mRNA to amplify a 111-bp fragment cDNA of
zebrafish abcc6a gene. The abcc6b primers (Fwd: 50-TCACGTGGT
ACACAGAACATCCAG-30; Rev: 50-AAGGCTACGGATAATAGGGC
TCAG-30) were placed on exons 2 and 3 of the corresponding mRNA
to amplify a 287-bp fragment cDNA of zebrafish abcc6b gene.
All RNA analyses used zebrafish b-actin as the control gene (Fwd:
50-ATCTGGCACCACACCTTCTACAATG; Rev: 50-GGGGTGTTGAA
GGTCTCAAACATGAT). PCR was performed using Qiagen Taq
polymerase and Q buffer (Qiagen, Valencia, CA), according to the
manufacturer’s instructions. The PCR contained 100 ng cDNA as
template and 50 ng of each primer in a final volume of 25 ml. Cycling
conditions for all primer pairs were 94 1C for 5 minutes, followed by
35 cycles of 94 1C for 1 minutes; 58 1C for 1 minutes; 72 1C for
1 minutes; and finally 72 1C for 10 minutes.
Analysis of the splice site morpholinos
The efficiency of the splice site morpholinos was monitored by
analysis of splicing using PCR amplification of abcc6a exons 7 and
8, and abcc6b exons 18 and 19, of the injected zebrafish embryo
cDNA. The abcc6a primers (Fwd: 50-GCATGTCCTGTTCAAGATG-30
on exon 7; Rev: 50-gctttgctgtccattcttcc-30 on exon 8) were used
to amplify a 174-bp cDNA fragment and 282-bp gDNA fragment.
The abcc6b primers (Fwd: 50-CTCTGTGGGTTATGTTCCTCAGCA-30
on exon 18; Rev: 50-TGTGTTGACCCACATGTGCATC-30 on exon 19)
were used to amplify a 299-bp cDNA fragment and 421-bp
gDNA fragment. The relative intensity of the bands was quantified
using ImageQuant version 5.0 software (Molecular Dynamics,
Sunnyvale, CA).
Whole mount in situ hybridization
In situ hybridization was performed as described previously
(Thisse and Thisse, 2008). Collected zebrafish embryos were fixed
in 4% paraformaldehyde before hybridization. To synthesize
digoxigenin-labeled antisense RNA probes, abcc6a in pCR2.1 vector
and abcc6b in pSPT18 vector were linearized by BamHI and HindIII,
respectively, and then transcribed with T7 RNA polymerase. After
hybridization, detection was performed with an anti-DIG antibody
coupled to alkaline phosphatase. Hybridization with sense probes
was performed as controls.
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mRNA rescue experiments
Capped, full-length mouse Abcc6 mRNA was synthesized from a
mouse cDNA expression vector using the mMessage mMachine kit
(Ambion, Austin, TX). The mRNA (9 ng) was microinjected into 1–4
cell stage embryos either alone or in combination with a morpholino
and the embryos were followed for viability and morphology.
Statistical analyses
Statistical analyses were conducted using SAS 9.2 (SAS Institute,
Gary, NC). Risk differences and 5% confidence intervals were
calculated between abcc6a- and scMO-injected groups with regard
to survival and phenotype at 3 and 5 d.p.f., separately. Fisher’s exact
test was used to determine differences between proportions because
of the presence of cells with zero percent survival or phenotype.
Adjustment for multiple comparisons was performed using False
Discovery Rate, which did not change the P-values appreciably, as
the largest raw P-value was 3.84E-08.
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